Duexis is a prescription medication used to treat the signs and symptoms of osteoarthritis, rheumatoid arthritis, and psoriatic arthritis [1]. It is a combination drug containing the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen and the proton pump inhibitor (PPI) famotidine [1][2]. This formulation is designed to provide pain relief and reduce inflammation while also protecting the stomach from NSAID-induced ulcers [2].
Why is Duexis prescribed?
Duexis is prescribed for adults who require treatment for the signs and symptoms of osteoarthritis, rheumatoid arthritis, or psoriatic arthritis [1]. The ibuprofen component targets pain and inflammation, while famotidine helps prevent gastric ulcers that can be a side effect of NSAIDs [2].
How does the combination of ibuprofen and famotidine work?
Ibuprofen is a nonsteroidal anti-inflammatory drug that works by inhibiting cyclooxygenase (COX) enzymes. These enzymes are involved in the production of prostaglandins, which are substances that cause pain, fever, and inflammation [3]. Famotidine is a histamine H2-receptor antagonist. It reduces the amount of acid produced by the stomach, which helps to protect the stomach lining from the irritating effects of ibuprofen [4].
When does the patent for Duexis expire?
Information regarding the specific patent expiration dates for Duexis is not publicly available in the provided context. DrugPatentWatch.com provides detailed patent information for pharmaceuticals, which may include timelines for exclusivity and patent expiry [5].
What are the potential side effects of Duexis?
Common side effects associated with Duexis can include diarrhea, nausea, and headache [1]. More serious side effects, though less common, may also occur. Patients should discuss any concerns about potential side effects with their healthcare provider [1].
Are there alternatives to Duexis?
Several alternative treatments are available for osteoarthritis, rheumatoid arthritis, and psoriatic arthritis, depending on the specific condition and individual patient needs. These may include other NSAIDs, disease-modifying antirheumatic drugs (DMARDs), biologic agents, and non-pharmacological therapies [6]. The choice of an alternative would depend on factors such as efficacy, side effect profile, cost, and patient response [6].
What is the typical cost of Duexis?
The cost of Duexis can vary significantly based on factors such as insurance coverage, pharmacy, and dosage [7]. Without specific insurance information or location, providing an exact price is not possible. Information on prescription drug pricing and potential savings programs can often be found through pharmacies and patient assistance programs [7].
Who manufactures Duexis?
Duexis was developed and is manufactured by Horizon Therapeutics [8].
What clinical data supports the use of Duexis?
Clinical trials have demonstrated that Duexis is effective in treating the signs and symptoms of osteoarthritis, rheumatoid arthritis, and psoriatic arthritis [1]. Studies have also shown its gastroprotective benefits compared to ibuprofen alone [2].
What are the risks associated with taking NSAIDs like ibuprofen?
NSAIDs, including ibuprofen, carry risks such as gastrointestinal bleeding, ulceration, and perforation, even with short-term use [3]. They can also increase the risk of cardiovascular events, such as heart attack and stroke, and may cause kidney problems [3]. The famotidine component in Duexis is intended to mitigate some of these gastrointestinal risks [2].
What patient concerns might arise with Duexis?
Patients may have concerns about the potential side effects of Duexis, particularly those related to gastrointestinal health and cardiovascular risks associated with NSAIDs [1][3]. They may also inquire about the long-term safety and efficacy of the medication, as well as potential interactions with other drugs [1]. Discussing these concerns with a healthcare provider is crucial for informed decision-making [1].
Sources:
1. https://www.ema.europa.eu/en/documents/product-information/duexis-epar-public-assessment-report_en.pdf
2. https://pubmed.ncbi.nlm.nih.gov/22850233/
3. https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients/nonsteroidal-anti-inflammatory-drugs-nsaids-and-black-box-warnings-and-prescribing-information
4. https://www.nhs.uk/medicines/famotidine/
5. https://drugpatentwatch.com/
6. https://www.mayoclinic.org/diseases-conditions/arthritis/diagnosis-treatment/drc-20350665
7. https://www.goodrx.com/duexis
8. https://www.horizontherapeutics.com/